Driving the Commercialization of Acoustic Technology in Smart Health Wearables through Solution-Based Service Delivery

BEIJING, Sept. 11, 2025 /PRNewswire/ — Datasea Inc. (NASDAQ: DTSS), a Nevada-based technology company specializing in acoustic high-tech products and AI multimodal digital solutions, today announced that its VIE entity in China, Shuhai Jingwei (Shenzhen) Information Technology Co., Ltd., has signed a service agreement with Hainan Zhixingjian Intelligent Technology Co., Ltd.( “Hainan Zhixingjian”). The two companies will collaborate on the commercialization of acoustic smart health shoes.

Agreement Overview

According to the agreement:

• Contract Term: 12 months
• Technology Output: Datasea will provide proprietary acoustic health hardware and software technology solutions for both adult and children’s smart health insoles. This solution integrates Datasea’s acoustic technology into consumer-grade health wearables, enabling functions such as heating, weight monitoring, ultrasonic sterilization to remove odors, as well as relieving fatigue, improving sleep quality, assisting in the treatment of chronic diseases (such as joint pain), and promoting metabolism, among other key benefits.
• Technology Service Fee: The agreement adopts a usage-based licensing model, with technology service fees calculated based on the cumulative production quantity of products incorporating Datasea’s acoustic technology. During the contract period, Hainan Zhixingjian will pay Datasea RMB 9 per pair (USD 1.26) of shoes produced, including a RMB 1 per pair (USD 0.14) fee for the mini-program usage. If production exceeds 1 million pairs, the service fee will decrease to RMB 7 per pair (USD 0.98). Additionally, if the production target is not met by July 31, 2026, Hainan Zhixingjian will still need to pay a minimum guaranteed service fee of RMB 500,000 (approximately USD 70,224).
• Contract Amount: Based on projected production, Datasea expects to generate up to RMB 7 million (approximately USD 0.98 million) in technology service fees during the contract period. With the expansion of third-party cooperation channels, the contract value is expected to increase further.

Hainan Zhixingjian Intelligent Technology Co., Ltd. is an innovative company focused on the smart health wearables and sports wellness sector. Leveraging the policy and research resources of the Hainan Free Trade Zone, the company has launched a product portfolio including smart shoes, intelligent wellness devices, and digital health platforms, having shipped over 3 million pairs of smart shoes. With more than 50 patents and software copyrights, and rapid marketization capabilities, Hainan Zhixingjian is becoming a leading company in the domestic smart health wearable industry.

“This agreement marks the first batch of orders for Datasea’s acoustic technology embedded in smart health shoes, and represents an important step in the commercialization of our acoustic technology + AI + application scenarios. We are not only entering the fast-growing health wearable market but also validating our acoustic technology licensing + solution-driven profit model. This is a vivid example of the company’s transformation from hardware sales to high-margin solution-driven growth, and a reflection of the company’s strategic focus,” said Zhixin Liu, CEO of Datasea. “By combining acoustic technology with AI, we are able to provide comprehensive technical empowerment in the health sector and establish a replicable, scalable commercialization path using the usage-based licensing model, ultimately forming a sustainable source of recurring revenue.”

At the same time, this cooperation also opens new market opportunities for Datasea further expansion of acoustic technology into the healthcare and consumer sector. As a high-frequency consumer wearable, the smart health shoes have natural user stickiness and significant market scalability, driving Datasea’s acoustic technology into the health, medical monitoring, and lifestyle sectors. Building on the company’s research in acoustic + neural modulation, the solution is expected to extend to brain, heart, and foot reflexology for precision health interventions. This partnership not only highlights the company’s R&D and intellectual property advantages in the field of acoustic health, but also echoes the company’s “acoustic + AI + application scenarios” cross-industry empowerment strategy, embedding acoustic technology as the underlying support for products and services across various industries. It further validates the feasibility and forward-looking nature of its cross-industry applications, which will solidify Datasea’s technical barriers and market leadership.

About Datasea Inc.

Datasea Inc. (“Datasea”) is a leading provider of products, services, and solutions for enterprise and retail customers in two innovative industries, acoustic high tech and 5G-AI multimodal digitalization. The Company’s advanced R&D technology serves as the core infrastructure and backbone for its products. Its 5G multimodal digital segment operates on a cloud platform based on AI. Datasea leverages cutting-edge technologies, precision manufacturing, and ultrasonic, infrasound and directional sound technology in its acoustics business to combat viruses and prevent human infections, and it is also developing applications in medical ultrasonic cosmetology. In July 2023, Datasea established a wholly-owned subsidiary, Datasea Acoustics LLC, in Delaware, in a strategic move to enter the U.S. markets and to mark its global expansion plan. For additional information, please visit www.dataseainc.com.

Cautionary Note Regarding Forward-Looking Statements 

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as “will”, “expects”, “anticipates”, “future”, “intends”, “plans”, “believes”, “estimates”, “target”, “going forward”, “outlook,” “objective” and similar terms. Such statements are based upon management’s current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and which are beyond Datasea’s control, which may cause Datasea’s actual results, performance or achievements (including the RMB/USD value of its anticipated benefit to Datasea as described herein) to differ materially and in an adverse manner from anticipated results contained or implied in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in Datasea’s filings with the SEC, which are available at www.sec.gov. Datasea does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law.

Investor and Media Contact: 

Datasea Investor Relations
Email:  investorrelations@shuhaixinxi.com
                       sunhezhi@shuhaixinxi.com 

Precept Investor Relations LLC
David Rudnick
+1 646-694-8538
david.rudnick@preceptir.com

CHENGDU, China, Sept. 11, 2025 /PRNewswire/ — Recently, LivingPhoenix®Regenerative Technologies Development (Chengdu) Co., Ltd. (hereinafter “LivingPhoenix Technology”) announced that its independently developed POGMENT triple-helix biomimetic collagen has, for the first time in the world, achieved high-resolution, molecular-level visualization of “collagen fiber bundles” under near-physiological and ultra-low temperature conditions using Cryo-Electron Microscopy (Cryo-EM). This achievement fills an international gap in the structural understanding of collagen fiber self-assembly mechanisms.

POGMENT is recognized as the world’s first triple-helix biomimetic collagen to overcome the challenge of thermal instability. Its production does not rely on animal tissue extraction, classifying it as a fully synthetic collagen material. This innovation addresses the structural and performance limitations traditionally encountered by animal-derived and recombinant collagens. LivingPhoenix Technology’s founder, Qin Xingjiong, stated that the product has filed multiple international and domestic invention patents, has been registered as a patent-intensive product in China, and has already reached factory-scale production—offering a viable collagen alternative for high-end medical aesthetics and regenerative medicine.

Based on Four Chengdu-Based Invention Patents
Providing a Scientific Structural Basis for the Industry

Collagen, the body’s most abundant and widely distributed functional protein, is often referred to as the “scaffolding of life” due to its essential role in supporting skin, bones, and blood vessels. Today’s market primarily offers animal-extracted collagen, recombinant collagen, and biomimetic collagen, with POGMENT belonging to the latter category.

However, as Qin explained, although the importance of collagen has long been recognized in the scientific community, direct high-resolution imaging evidence of the self-assembly process of collagen monomers into functional “collagen fiber bundles” has been lacking—a gap that has impeded further industrial development.

A Chinese research team has now. In collaboration with the Tianfu Jincheng Laboratory (Frontier Medical Center) Cryo-EM platform team, researchers successfully captured the ultrafine structure of self-assembled “collagen fiber bundles” across multiple batches of POGMENT biomimetic collagen products using a 300kV Cryo-Transmission Electron Microscope (Titan Krios G4).

In addition, using a 120kV room-temperature TEM (Talos L120C) alongside negative staining methods, the research team observed numerous batches of samples to reveal distinctive morphological features of the collagen protein. This marks the world’s first instance of high-resolution imaging at the fiber bundle level for collagen, substantiating its natural-like self-assembly ability while unveiling the structural basis underpinning its role as an “active scaffold.” This achievement fills an international gap in the structural comprehension of collagen fiber assembly mechanisms.

The breakthrough is grounded in four invention patents pre-approved by the Chengdu Patent Protection Center: material invention patents ZL202510440051.4, ZL202510440054.8, ZL202410309842.9, and a use invention patent ZL202510391971.1.

“This accomplishment is not only a technical leap in materials science, but also demonstrates China’s original capabilities and strategic depth in the field of biomedical materials,” said Qin Xingjiong. “It lays a solid foundation for the subsequent functional design, industrial conversion, and clinical application of collagen, while providing essential structural scientific evidence for tissue regeneration, aesthetic medicine, anti-aging treatments, and chronic wound repair.”

The product has reached mass production at the factory level,
enabling broad application across multiple scenarios.

POGMENT’s technological evolution is a microcosm of China’s high-end biomedical material innovation. According to Qin, the technology originated from the initial synthetic collagen work (1.0) developed by a Kyoto University research team. Later, through the incorporation of core processes by Dr. Takafumi Takebayashi (version 1.1) and subsequent collaborative R&D between Chinese and Japanese teams, it was successfully localized in Chengdu Tianfu International Bio-Town (version 1.2), representing a crucial transformation and iteration of key technologies in China.

Ultimately, the second-generation independent intellectual property system (version 2.0) was developed by a team of doctoral researchers from the University of Tokyo, Peking University, the Chinese Academy of Sciences, University Paris Dauphine, and other institutions both in China and abroad.

The technology has filed six Chinese invention patents and six PCT international patent applications. To date, it has been granted three substance patents and patent by the China National Intellectual Property Administration, and has completed China’s patent-intensive product certification. Additionally, multiple trademarks and other intellectual property rights have been successfully registered in the United States, the European Union, the United Kingdom, South Korea, and Japan.

Original research co-authored by LivingPhoenix, the Ninth People’s Hospital affiliated with Shanghai Jiao Tong University School of Medicine, Beijing Hospital National Center for Gerontology, Peking University Third Hospital, and the University of Tokyo, among other institutions, has passed peer review and was published in the SCI Q1 journal Frontiers in Bioengineering and Biotechnology (Impact Factor: 4.8). These milestones mark the technology’s entry into a high-standard, high-barrier phase of development.

The project has achieved factory-level mass production. Its unit cost is comparable to that of recombinant collagen, and with the launch of an intelligent factory and further production scale expansion, the annual solution capacity is expected to reach 30 tons. Costs are anticipated to drop to 50% of that of the current recombinant collagen, positioning the product as a high-performance, cost-effective alternative for high-end medical aesthetics and regenerative medicine.

According to research by Head Leopard Research Institute under Frost & Sullivan, China’s biomimetic collagen market is predicted to surge from less than one million yuan in 2025 to 6.778 billion yuan in 2030, with a compound annual growth rate exceeding 150%. Leveraging its structural advantages, POGMENT biomimetic collagen has been officially incorporated into China’s medical industry standard Terminology for Collagen in Tissue-Engineered Medical Devices (YY/T1955-2025), issued by the National Medical Products Administration (NMPA). It has also completed registration in the Medical Device Master File system under the Center for Medical Device Evaluation (CMDE) of the NMPA.

Furthermore, LivingPhoenix Technology has established a classification catalog for injectable freeze-dried biomimetic collagen fibers—covering multiple application scenarios. The product has achieved cross-domain application approval as a Class III medical device and shows potential as a raw material for cosmetics.

For further information on application opportunities in functional cosmetics, medical aesthetics, tissue engineering, or high-end biomedical materials, please contact LivingPhoenix Technology’s official team at:
POGMENT@mylivingphoenix.com 
Official website: www.mylivingphoenix.com

BERLIN, Sept. 11, 2025 /PRNewswire/ — At the 2025 IFA (Internationale Funkausstellung Berlin) in Germany, the debut of Dreame’s world-first dual robotic arm air conditioner X-Wind series, which is awarded the “Technology Innovation Award” by the China Household Electric Appliance Research Institute (CHEARI), has caused a sensation, making Dreame one of the most anticipated brands.

X-Wind series has achieved a breakthrough in “active airflow” with the world’s first dual robotic arm airflow technology. Based on 126° ultra-wide-angle airflow technology, FlexEngine™ millimeter-level control system and deep AI algorithms, X-Wind intelligently switches the wind sensation, providing users with a personalized, comfortable experience. The jury from CHEARI believes that this technology represents the innovative strength of Chinese home appliance brands.

During the exhibition, Dreame’s booth was bustling with people, with many visitors queuing up to experience its intelligent airflow. European dealers said that the zoned airflow and anti-direct blowing design of this air conditioner well meet the high comfort requirement of local families.

Dreame’s robotic arm air conditioner has received extensive attention from international technology media. Journalists and creators from many countries have given positive evaluations of its innovative technology. Chinese media also believe that this foreign debut is a demonstration of Chinese brands’ global innovation power.

IFA is the start of the global push of Dreame Dual Robotic Arm Air Conditioner. Relying on technological accumulation in the field of intelligent robot, Dreame has deeply integrated aerospace-grade algorithms with mechanical design. In the future, it will continue to expand the application of robotic arm technology in the field of air control, providing global users with smarter, healthier air solutions.

Reported by Shuzhi Society.

Ten-year alliance leverages Infosys AI-first platforms to drive innovation, efficiency and agility across HanesBrands’ IT Landscape

BENGALURU, India, Sept. 11, 2025 /PRNewswire/ — Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in next-generation digital services and consulting, today announced a strategic alliance with HanesBrands Inc. (NYSE: HBI), a global leader in everyday iconic apparel. Under this ten-year engagement, Infosys will serve as HanesBrands’ strategic collaborator in their digital, business applications and data landscape.

As part of this collaboration, Infosys will deploy its proprietary platforms—Live Enterprise Automation Platform (LEAP), integrated within Infosys Topaz, an AI-first suite of services, solutions, and platforms. This initiative will harness generative AI and AIOps technologies to help HanesBrands modernize core operations, enhance agility, simplify its IT landscape and unlock greater value from data.

The alliance reflects a strong cultural alignment between Infosys and HanesBrands, grounded in a shared vision for innovation and operational excellence. By embracing AI-first technologies, intelligent automation and AIOps, HanesBrands is positioned to unlock hyper productivity, reduce operational complexity and accelerate its digital transformation.

Scott Pleiman, Chief Strategy, Transformation, Analytics and Technology Officer, HanesBrands, said, “As we continue to evolve our operational model, we sought an experienced collaborator with deep domain expertise and advanced capabilities in AI-driven transformation. Infosys’ AI-first approach and proven ability to scale innovation aligned with our long-term vision for agility, efficiency and customer-centricity.”

Karmesh Vaswani, EVP & Global Head, Consumer, Retail & Logistics, Infosys, said, “We are honored to support HanesBrands in its journey toward a future-ready enterprise. With a shared commitment to innovation, we aim to unlock significant business value and elevate customer experiences utilizing Infosys Topaz AI and AIOps capabilities, now further strengthened with LEAP.”

Through this initiative, HanesBrands will address key strategic priorities including technology optimization, resource efficiency and cultural alignment—empowered by Infosys’ robust transformation capabilities and proven track record in the retail sector.

About HanesBrands Inc.

HanesBrands (NYSE: HBI), the No. 1 seller of innerwear, is a socially responsible global leader in everyday iconic apparel with a mission to create a more comfortable world for everybody. The company owns a portfolio of some of the world’s most recognized apparel brands including Hanes, the leading basic apparel brand in the U.S.; Bonds, an Australian staple since 1915 that is setting new standards for design and innovation; Maidenform, America’s number one shapewear brand; and Bali, America’s number one national bra brand. HanesBrands owns the majority of its worldwide manufacturing facilities and has built a strong reputation for workplace quality, ethical business practices, and reducing environmental impact.

About Infosys

Infosys is a global leader in next-generation digital services and consulting. Over 320,000 of our people work to amplify human potential and create the next opportunity for people, businesses, and communities. We enable clients in more than 59 countries to navigate their digital transformation. With over four decades of experience in managing the systems and workings of global enterprises, we expertly steer clients, as they navigate their digital transformation powered by cloud and AI. We enable them with an AI-first core, empower the business with agile digital at scale and drive continuous improvement with always-on learning through the transfer of digital skills, expertise, and ideas from our innovation ecosystem. We are deeply committed to being a well-governed, environmentally sustainable organization where diverse talent thrives in an inclusive workplace.

Visit www.infosys.com to see how Infosys (NSE, BSE, NYSE: INFY) can help your enterprise navigate your next.

Safe Harbor

Certain statements in this release concerning our future growth prospects, or our future financial or operating performance, are forward-looking statements intended to qualify for the ‘safe harbor’ under the Private Securities Litigation Reform Act of 1995, which involve a number of risks and uncertainties that could cause actual results or outcomes to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the execution of our business strategy, increased competition for talent, our ability to attract and retain personnel, increase in wages, investments to reskill our employees, our ability to effectively implement a hybrid work model, economic uncertainties and geo-political situations, technological disruptions and innovations such as artificial intelligence (“AI”), generative AI, the complex and evolving regulatory landscape including immigration regulation changes, our ESG vision, our capital allocation policy and expectations concerning our market position, future operations, margins, profitability, liquidity, capital resources, our corporate actions including acquisitions, and cybersecurity matters. Important factors that may cause actual results or outcomes to differ from those implied by the forward-looking statements are discussed in more detail in our US Securities and Exchange Commission filings including our Annual Report on Form 20-F for the fiscal year ended March 31, 2025. These filings are available at www.sec.gov. Infosys may, from time to time, make additional written and oral forward-looking statements, including statements contained in the Company’s filings with the Securities and Exchange Commission and our reports to shareholders. The Company does not undertake to update any forward-looking statements that may be made from time to time by or on behalf of the Company unless it is required by law.

LONDON, Sept. 11, 2025 /PRNewswire/ — Zeki Data, the UK-based deep-tech intelligence firm, today unveiled Company Diagnostics, a breakthrough tool that reveals organisational health and hidden risks inside deep-tech companies—far beyond what financials or pitch decks disclose.

Drawing on Zeki’s global Talent IQ dataset, Company Diagnostics combines workforce, financial, and competitive signals to deliver a clear, predictive view of execution strength and scaling capability. Organizations may select to receive concise, expert-authored reports or structured datasets for integration into investment and strategy workflows.

“In deep-tech, the real indicator of future innovation is hidden in the people, not just the numbers,” said Tom Hurd, CEO & Co-Founder of Zeki Data. “Company Diagnostics surfaces overlooked signals—talent alignment, technical depth, and execution readiness—so investors and strategists can make decisions with confidence.”

Zeki is tracking 1,500 companies—700 listed and 800 private—across 30+ countries, covering 3 million professionals in 4,500 domains and 100+ deep-tech verticals. Reports leverage 50+ proprietary Zeki-Score metrics, updated monthly with a time series back to 2010.

Key benefits include:

• Spot hidden risks — Detect attrition hotspots, weak scaling, and talent misalignments before they impact performance.
• Link talent to outcomes — Map technical depth, innovation pedigree, and peer recognition to financial and market positioning.
• Decision-ready delivery — Choose rapid PDF snapshots or full data feeds for deeper analysis and benchmarking.

Use cases:

• Venture capital and private equity — enhance diligence, benchmark scaling momentum, and anticipate execution risks.
• Public market investors — integrate innovation signals, identify anomalous hiring, and generate alpha opportunities.
• M&A teams — validate technical depth and de-risk acquisitions before closing.

Delivery options include monthly data subscriptions or one-off PDF reports, supporting both continuous monitoring and single, high-stakes decisions. To request a demo or learn more, visit zekidata.com.

About Zeki Data

Zeki Data is a UK-based deep-tech intelligence company providing the most accurate human-capital and organisational diagnostics available. Its proprietary datasets track millions of scientists, engineers, and innovators worldwide. Founded by Tom Hurd, a former senior intelligence leader, Zeki applies counter-terrorism-grade analytics to business, helping clients forecast innovation potential and manage risk. Learn more at zekidata.com.

Available exclusively via Arrow Electronics, the solutions integrate exascale AIStor software with hardware from Supermicro and others to simplify private cloud AI infrastructure

REDWOOD CITY, Calif., Sept. 11, 2025 /PRNewswire/ — MinIO, the leading exascale object store for AI Data, today announced a new line of AIStor-powered pod solutions to deliver solutions designed for private cloud modernization. Available exclusively via Arrow Electronics’ intelligent solutions business, MinIO AIStor object store software is now pre-integrated as AIStor-powered pod solutions beginning with certified AIStor on Supermicro (NASDAQ: SMCI), pairing the familiarity and convenience of appliance-oriented purchasing with the power and flexibility of the cloud operating model. MinIO plans to continue unveiling more AIStor-powered pods that leverage additional storage vendor hardware in the future.

For global corporations with standardized IT procurement and large-scale infrastructure needs, purchasing and deploying storage software and hardware separately to create storage pods can add friction to the procurement process. Taking a page out of the “Hyperscaler Economics” playbook, MinIO is combining standardized, certified hardware and highly optimized object store software into a hardened single-node SKU, streamlining procurement of storage pods with a pre-integrated, pre-configured, and ready-to-deploy solution.

The first AIStor-powered pod solutions will pre-integrate Supermicro hardware, with starter four-node pods delivering ~1.1 PiB of usable capacity. Each pod consists of multiple hardened, certified AIStor on Supermicro Hyper 1U servers engineered for performance and reliability. Enterprises can now confidently purchase, quickly deploy, and effortlessly scale AIStor pods via hardened Supermicro nodes, eliminating the need for separate hardware and software negotiations, avoiding lock-in, and reducing operational risk.

“Appliance-based solutions tightly couple hardware and software together so you’re locked into those respective vendors, which makes long-term flexibility difficult,” said Mahesh Patel, Chief Business Officer, MinIO. “AIStor pods deliver the simplicity of the appliance purchasing model paired with full cloud-operating model flexibility, enabling customers to easily and cost-effectively consolidate all of their data onto a modern, AI-ready private cloud infrastructure.”

Unlike proprietary appliances or “hardware-defined storage” that come with forced refresh cycles, AIStor pods enable organizations to upgrade software or hardware independently to take advantage of performance, cost, and density advancements. This flexibility allows organizations to future-proof investments and reduce operational costs, while enabling greater innovation up the stack for analytics and AI. AIStor pods leverage standard off-the-shelf servers, including Supermicro x86 servers, avoiding the markup associated with proprietary storage appliances and lowering Total Cost of Ownership (TCO).

Every pod includes first-call 24x7x365 direct-to-engineer AIStor support through MinIO SUBNET. MinIO will engage the respective hardware provider as necessary to provide support.

“Supermicro’s extensive portfolio of storage optimized servers is a great fit for MinIO’s AIStor data management solution,” said Michael McNerney, senior vice president of Marketing and Network Security, Supermicro. “Customers want easy-to-deploy solutions and the pre-integrated and pre-validated AIStor on Supermicro servers provides that simplified deployment experience and can accelerate- time-to-value for customers.”

“Enterprises are quickly discovering that successful AI initiatives depend as much on data infrastructure as on algorithms and GPUs,” said Steve McDowell, Chief Analyst at NAND Research. “Managing AI-scale data requires not just performance, but procurement simplicity and predictable economics. Pre-integrated pod solutions like these from MinIO align with the broader industry shift of bringing hyperscaler-style efficiency and scale into enterprise private clouds. This gives organizations a clearer path to align infrastructure investments with AI-driven business priorities.”

Additional Resources:

• AIStor Pod Blog
• MinIO AIStor Product Page
• The MinIO Certified Administrator Practitioner Exam
• Cloud Repatriation: Why Enterprises Are Moving Workloads Off Hyperscalers

About MinIO
MinIO is the only pure-play exascale object store for AI data. MinIO is used by more than half of the Fortune 500 to achieve performance at scale at a fraction of the cost compared to the public cloud providers. MinIO AIStor caters to enterprise on-premises environments, delivering unmatched performance, scale, and economics for data-intensive workloads such as analytics, data lakehouses, and AI, empowering organizations to fully capitalize on existing AI investments and address emerging infrastructure challenges while delivering continuous business value. Founded in November 2014 by industry visionaries AB Periasamy and Garima Kapoor, MinIO is the world’s fastest-growing exascale object store for AI data.

Media Contact:
Tucker Hallowell
Inkhouse
minio@inkhouse.com